Vol. 23 No. 3 (2025): Blood Transfusion 3-2025 (May-June)
Full Issue
pdf
Original article
-
Exploring MSM blood donor profiles: a descriptive analysis of demographics, risk characteristics, and donation behaviors: MSM Blood Donor Profiles
-
ELP protocol: an original approach for the mitigation of anti-CD38 interference: ELP protocol in the mitigation of anti-CD38 interference
-
Perinatal outcome in pregnant women: the impact of blood transfusion: Blood transfusion and pregnancy
-
A survey on the implementation of Patient Blood Management programs in Italy: First national survey with 2018 PBM data
-
Patient Blood Management in 2023: a Nationwide Survey of Anesthesiologists in Romania following the 2018 Guidelines: National survey on PBM in 2023
-
Efficiency assessment of cord blood banking and compatibility with delayed cord clamping: Delayed cord clamping is compatible with cord blood banking
-
Evaluation of platelet function by Total Thrombus-Formation Analysis System (T-TAS®01) in term and preterm infants and its relationship with patent ductus arteriosus. A prospective observational pilot study: T-TAS®01, platelet, and patent ductus arteriosus in newborns
Case report
Announcements
Winter Closure
The Editorial Office will be closed from December 31 to January 7, 2026.
Season’s greetings to all our readers, authors, and reviewers.
Read moreSIMTI 2026
46° Convegno Nazionale di Studi di Medicina Trasfusionale - Abstract Book (in Italian)
Read moreSETS 2026
35° Congreso de la Sociedad Española de Transfusión Sanguínea y Terapia Celular - SETS - Abstract Book (in Spanish), is online (https://www.bloodtransfusion.it/bt/issue/view/81).Madrid, 4-6 June 2026.
Read moreEditorial Office Closure Notice
Please note that the BT Editorial Office will be closed until August 26, 2026.
During this period, responses to inquiries and the processing of manuscripts may be delayed. All editorial activities will resume as usual after this date.
Thank you for your understanding.
Best regards,
BT Editorial Office
Read more
Impact Factor 2025
We are pleased to announce that Blood Transfusion has achieved a 2025 Impact Factor of 2.7.
Read more
